Danielle Greenawalt

<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma

Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt et al. · Cancer Discovery · 2018 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +16

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson et al. · Cancer Immunology Research · 2016 · 423 citations

Medicine, Immunology, Oncology +16

Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer

Nataly Manjarrez‐Orduño, Laurence Ménard, Selena Kansal et al. · Frontiers in Immunology · 2018 · 129 citations · Full text

Life Sciences, Immunology, Oncology +17

Gene expression profiling of esophageal cancer: Comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma

Danielle Greenawalt, Gordon K. Smyth, Marianne L. Ciavarella et al. · International Journal of Cancer · 2007 · 92 citations · Full text

Medicine, Molecular Biology, Oncology +17

Pretreatment Gene Expression Profiles Can Be Used to Predict Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Danielle Greenawalt, Adam Kowalczyk, Marianne L. Ciavarella et al. · Annals of Surgical Oncology · 2007 · 66 citations

Medicine, Bioinformatics, Oncology +13